New therapeutic perspectives for demyelinating retrobulbar optic neuritis

Italian Journal of Neurological Sciences

Volumn 19, Issue 1, 1998, Pages 45-48

  Curro Dossi, B ^a   Amadori, A ^a   Cirafisi, C ^a   Lorusso, S ^a   Pasquinelli, M ^a   Piscaglia, M G ^a   Ravasio, A ^a  

^a Infermi Hospital   (Italy)

Author keywords

Acute demyelinating optic neuritis; Intravenous immunoglobulin therapy; Multiple sclerosis

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG RESISTANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; RETROBULBAR OPTIC NEUROPATHY; TREATMENT OUTCOME; ACUTE DISEASE; DEMYELINATING DISEASE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; VISUAL ACUITY;

ACUTE DISEASE; ADULT; DEMYELINATING DISEASES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0031593283     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03028812     Document Type: Article

References (14)

1. Beck RW, Cleary PA, Andersen MM et al ( 1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 326:581-588
2. Beck RW, Cleary PA, Backlund JC et al ( 1994) The course of visual recovery after optic neuritis. Ophthalmology 101:1771-1778
3. Curro Dossi B, Tezzon F (1987) High-dose intravenous gammaglobulin in chronic inflammatory demyelinating polyneuropathy. Ital J Neurol Sei 8:321-326
4. Dyck PJ, Litchy WJ, Kratz KM et al (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36:838-845
5. Kleyweg RP, van der Mèche' FGA, Meulstee J (1988) Treatment of Guillain-Barre's syndrome with high-dose gammaglobulin. Neurology 38:1639-1641
6. Van Doom PA, Breand A, Strengers PFW et al (1990) Highdose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double blind placebo-controlled cross over study. Neurology 40:209-212
7. Vermeulen M, Van Doom PA, Brand A et al (1993) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: A doubleblind, placebo controlled study. J Neurol Neurosurg Psychiatry 56:36-39
8. Van Engelen BGM, Hommes OR, Pinckers A et al (1992) Improved vision after intravenous immunoglobulin in stable demyelinating optic neurits. Ann Neurol 32:834-835
9. Kaveri SV, Mouthon L, Kazatchkine MD (1994) Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory disease. J Neurol Neurosurg Psychiatry 57 (Suppl.):6-8
10. Van Schaik IN, Vermeulen M, Brand A ( 1994) In vitro effects of polyvalent immunoglobulin for intravenous use. J Neurol Neurosurg Psychiatry 57 (Suppl.): 15-17
11. Van Engelen BGM, Miller DJ, Pavelko KD et al (1994) Promoting of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. J Neurol Neurosurg Psychiatry 57 (Suppl.):65-68
12. Rodriguez M, Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27:12-17
13. Noseworthy JH, O'Brien PC, van Engelen BGM et al (1994) Intravenous immunoglobulin therapy in multiple sclerosis: Progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial. J Neurol Neurosurg Psychiatry 57 [Suppl]: 11-14
14. Rodriguez M, Miller DJ, Lennon VA (1996) Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology 46:538-545